Disclosure Panels Details Page
Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenström Macroglobulinemia Panel - Disclosures as of 03/29/2021
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Kehinde Adekola MD, MSCI | Blood and Marrow Transplant Clinical Trials Network - BMT CTN | None | None | None | ✔ |
| Larry Anderson, Jr. MD, PhD | Amgen Inc. Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP Karyopharm Therapeutics |
Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Oncopeptides |
Celgene Corporation GlaxoSmithKline Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Oncopeptides |
None | ✔ |
| Muhamed Baljevic MD | Amgen Inc. Bristol-Myers Squibb Company Exelixis Inc. Karyopharm Therapeutics |
None | AlphaSights Aptitude Health Case Series on Hematologic Malignancies Atheneum Bristol-Myers Squibb Company Cardinal Health Specialty Solutions Oncology Coleman Research GLG individual consultations Guidepoint Global Karyopharm Therapeutics MediCom Worldwide Inc. MM MRD Roundtable clonoSEQ NCCN 2020 Virtual Congress: Hematologic Malignancies Putnam Associates Trinity Partners |
None | ✔ |
| Ryan Berardi MSc | None | None | None | None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| Natalie Callander MD | None | None | None | None | ✔ |
| Erica Campagnaro MD | None | None | None | None | - |
| Jorge Castillo MD | AbbVie, Inc. BeiGene Janssen Pharmaceutica Products, LP Pharmacyclics TG Therapeutics |
BeiGene Janssen Pharmaceutica Products, LP Pharmacyclics Roche Laboratories, Inc. |
None | None | ✔ |
| Caitlin Costello MD | Multiple Myeloma Research Foundation | Celgene Corporation Karyopharm Therapeutics Oncopeptides Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Srinivas Devarakonda MD | None | None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Mary Dwyer MS | None | None | None | None | - |
| Noura Elsedawy MD | None | None | None | Vyriad | ✔ |
| Colleen Erb MSN, AOCNP, CRNP | None | None | None | None | - |
| Matthew Faiman MD, MBA, FACP | None | None | None | None | ✔ |
| Alfred Garfall MD | Janssen Pharmaceutica Products, LP Novartis Pharmaceuticals Corporation Tmunity Therapeutics |
GlaxoSmithKline Janssen Pharmaceutica Products, LP |
None | University of Pennsylvania, royalties on licensed IP in the field of CAR T cell therapy. | ✔ |
| Kelly Godby MD | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | - |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Jens Hillengass MD, PhD | None | Oncopeptides sanofi-aventis U.S. Skyline |
Beijing Medical Award Foundation Curio Science Rapid Payer Response Research to Practice |
None | ✔ |
| Leona Holmberg MD, PhD | Bristol-Myers Squibb Company Janssen Pharmaceutica Products, LP Merck & Co., Inc. sanofi-aventis U.S. Seattle Genetics, Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | Up-To-Date | ✔ |
| Myo Htut MD | Celgene Corporation | Janssen Pharmaceutica Products, LP | None | None | ✔ |
| Carol Ann Huff MD | GlaxoSmithKline Glenmark / Ichnos Oncopeptides sanofi-aventis U.S. |
GlaxoSmithKline Oncopeptides sanofi-aventis U.S. |
None | None | ✔ |
| Malin Hultcrantz MD, PhD | Amgen Inc. Daiichi- Sankyo Co. GlaxoSmithKline |
None | None | None | ✔ |
| Yubin Kang MD | Apogee Biotech and RedHill Pharmaceutical Co | None | sanofi-aventis U.S. | None | ✔ |
| Rashmi Kumar PhD | None | None | None | None | - |
| Shaji Kumar MD | AbbVie, Inc. Allogene Bristol-Myers Squibb Company Carsgen Celgene Corporation GlaxoSmithKline MedImmune Inc. Oncogene Roche Laboratories, Inc. Takeda Pharmaceuticals North America, Inc. Tenebio |
AbbVie, Inc. BeiGene Celgene Corporation Cellectar GlaxoSmithKline Oncopeptides Roche Laboratories, Inc. sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | ✔ |
| Sarah Larson MD | AbbVie, Inc. Bristol-Myers Squibb Company Celgene Corporation Janssen Pharmaceutica Products, LP Juno Therapeutics, Inc. |
None | None | None | ✔ |
| Michaela Liedtke MD | Allogene Bristol-Myers Squibb Company Caelum Celator Pharmaceuticals Celgene Corporation Genentech, Inc. Janssen Pharmaceutica Products, LP Seattle Genetics, Inc. |
Alnylam Bristol-Myers Squibb Company GlaxoSmithKline Karyopharm Therapeutics Kite Pharma Kura Oncology, Inc. Oncopeptides sanofi-aventis U.S. |
Amgen Inc. Pfizer Inc. |
None | ✔ |
| Thomas Martin MD | Amgen Inc. Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Seattle Genetics, Inc. |
GlaxoSmithKline | None | None | ✔ |
| John Murphy | None | None | None | None | - |
| James Omel MD | None | None | None | none | ✔ |
| James Polson BSRT (R) (CT) (MR) | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Douglas Sborov MD, MSc | Amgen Inc. Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP |
GlaxoSmithKline Janssen Pharmaceutica Products, LP sanofi-aventis U.S. SkylineDX |
None | None | ✔ |
| Kenneth Shain MD, PhD | AbbVie, Inc. Karyopharm Therapeutics |
Bristol-Myers Squibb Company GlaxoSmithKline |
Amgen Inc. Bristol-Myers Squibb Company GlaxoSmithKline Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | ✔ |
| Keith Stockerl-Goldstein MD | BioLIne Caelum Bioscineces GlaxoSmithKline Ionis Janssen Pharmaceutica Products, LP sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | Abbott Laboratories|AbbVie, Inc.|Novartis Pharmaceuticals Corporation | ✔ |
| Donna Weber MD | None | None | None | None | - |